Methadone Maintenance Treatment and Smoking Cessation
Status:
Unknown status
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The main hypotheses guiding the study are:
1. Stable methadone maintenance patients receiving varenicline will be more likely to
maintain abstinence than patients receiving placebo
2. There will be no differences in the type and number of symptoms reported between stable
methadone maintenance patients receiving varenicline and placebo
3. There will be no changes in methadone dosage between abstinent and non-abstinent smokers
4. There will be no differences in efficacy, withdrawal symptoms, and safety of varenicline
between male and female participants
Phase:
Phase 2
Details
Lead Sponsor:
Vancouver Coastal Health
Collaborator:
British Columbia Centre of Excellence for Women's Health